Methylphenidate Hydrochloride 55466-0103-12
- Manufacturer
- Neolpharma, Inc.
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- March 29, 2024
- Listing Expires
- December 31, 2026
- Application
- ANDA208737
Active Ingredients
| Ingredient | Strength |
|---|---|
| Methylphenidate Hydrochloride | 20 mg/1 |
Drug Class
Central Nervous System Stimulant [EPC]Central Nervous System Stimulation [PE]
Selected Package
55466-0103-12Selected100 TABLET in 1 BOTTLE (55466-103-12)